Hologic, Inc. (HOLX)

72.35
NASDAQ
Prev Close 70.41
Day Low/High 67.88 / 72.46
52 Wk Low/High 26.49 / 85.00
Exchange NASDAQ
Shares Outstanding 257.66B
Market Cap 18.14B
P/E Ratio 17.98
Div & Yield N.A. (N.A)

Hologic upgraded at Barclays

Hologic downgraded at Piper

New CEO, Carl Icahn Stake Boost Hologic

New CEO, Carl Icahn Stake Boost Hologic

It's time to take some profits on the company's success.

Hologic, Marks & Spencer and Sensata Set to Enjoy Strong Growth

Hologic, Marks & Spencer and Sensata Set to Enjoy Strong Growth

Hologic is seeing huge demand for its 3-D mammography machines and it is still early in the adoption cycle, said Leah Bennett, Co-Chief Investment Officer for South Texas Money Management.

Hologic upgraded at Canaccord

Keep Buying the Dips in 2015

Keep Buying the Dips in 2015

Underlying fundamentals are in place for a healthy stock market.

Hologic upgraded at BTIG

Making a List, Checking It Twice

Making a List, Checking It Twice

Here's what we'd be buying into weakness for 2015.

Superior Management Makes a Huge Difference

Superior Management Makes a Huge Difference

Invest in companies whose management teams inspire confidence.

The Election Cycle Is Good for Stocks

The Election Cycle Is Good for Stocks

Investing during a mid-term election can offer large returns.

Buy Into Those Fear-Driven Selloffs

Buy Into Those Fear-Driven Selloffs

There is a disconnect between stock prices and intrinsic value.

Everyone's Looking Up, but Should Be Looking Down

The Carl Icahn lesson. "Also-Ran Surprise No. 5: Carl Icahn's fund loses 15% to 20%." -- Kass Diary, 15 Surprises for 2014. By my calculation (below) Carl Icahn's portfolio (of individual stock holdings) has lost more than $6 billion from the recent...

Activists Push Stock Prices Higher

Activists Push Stock Prices Higher

Corporate activism should continue to be a positive for stock prices.

Hologic downgraded at BTIG

Catching Up With Three Takeover Targets

Catching Up With Three Takeover Targets

Hologic, Symantec and TE Connectivity could all benefit from the current M&A binge.

Mergers and Acquisitions Are Back in Play

Mergers and Acquisitions Are Back in Play

Spice up your portfolio with some takeover bait.

Slow-and-Steady Winners

Slow-and-Steady Winners

Six stocks poised to deliver favorable returns for the balance of the year.

Time to Load Up on Hologic

Time to Load Up on Hologic

Positive developments and an attractive entry point make the stock a table-pounding buy.

Updating the Market's Road Map

Updating the Market's Road Map

Buy the dips and don't chase the rallies.

That Was the Week That Was

That Was the Week That Was

Let's review.

Hologic Makes the Right Moves

Hologic Makes the Right Moves

They should improve shareholder value in coming months.

Hologic downgraded at Morgan Stanley

Icahn's Actions to Drive Hologic Higher

Icahn's Actions to Drive Hologic Higher

Hologic should benefit from a greater sense of urgency.

Passing on Hologic

Buying based on price in a mature bull market is not a recipe for success. Subscriber HG, thanks for the Stifel report on Hologic (HOLX). I am passing on this name as there appears to be no catalyst over the near term. Buying based on price in a mat...

From the Street of Dreams

Hologic's price target gets trimmed. Citigroup reiterates its neutral rating on Hologic (HOLX) but lowers its price target by $2 per share to $22. Staying away.

Hologic Reappears

After its miss, is it a value? Is there anyone on site who has a fundamental view of Hologic (HOLX)? This is an old name I have been long from in the past, and it used to be a large Omega Advisors holding. Prima facie, it looks like value despite th...

Hologic downgraded at Canaccord

Hologic downgraded at William Blair

Hologic downgraded at RBC